Windward Bio Plans IPO
Swiss biotechnology company Windward Bio has filed to go public in the United States, seeking to advance experimental antibody treatments for respiratory and inflammatory diseases amid renewed activity in the biotech IPO market. ◉ Key points ◉ Nasdaq listing planned: Windward Bio intends to trade under the ticker WWB. The preliminary registration statement does not
Windward Bio Plans IPO Read More »












